Related Experiment Video
Updated: Feb 25, 2026
Modeling Brain Metastases Through Intracranial Injection and Magnetic Resonance Imaging
Published on: June 7, 2020
Imaging of Neuroendocrine Tumors: Indications, Interpretations, Limits, and Pitfalls
1Division of Endocrinology, Diabetes & Metabolism, UCLA David Geffen School of Medicine, 200 Medical Plaza Driveway #530, Los Angeles, CA 90095, USA.
Abstract:
Imaging is critical in the diagnosis, prognosis, and management of neuroendocrine tumors (NETs). NETs share common imaging features, but each type exhibits unique features. Computed tomography scans or MRI of the abdomen is used to assess tumor burden routinely. Functional imaging with octreotide scan or gallium-68 somatostatin analog PET is used selectively to confirm diagnosis and guide therapy. Clinicians and radiologists should be familiar with the indications and interpretations of imaging modalities. Novel functional imaging modalities likely will be developed to detect small NETs, predict prognosis, guide therapeutic choices, and design novel therapies.
Insights
Imaging plays a vital role in diagnosing and managing neuroendocrine tumors (NETs). Understanding various imaging techniques, from CT scans to advanced PET scans, is crucial for effective patient care and future treatment development.
Area of Science:
- Oncology
- Radiology
- Medical Imaging
Background:
- Neuroendocrine tumors (NETs) require precise imaging for diagnosis, prognosis, and treatment planning.
- While NETs share some imaging characteristics, distinct features vary among tumor types.
- Current standard imaging includes CT and MRI for assessing tumor burden.
Purpose of the Study:
- To review the critical role of various imaging modalities in the management of neuroendocrine tumors (NETs).
- To highlight the importance of familiarity with imaging indications and interpretations for clinicians and radiologists.
- To discuss the potential of novel imaging techniques in improving NET detection and treatment.
Main Methods:
- Review of established and emerging imaging techniques for neuroendocrine tumors.
- Discussion of computed tomography (CT) and magnetic resonance imaging (MRI) for tumor burden assessment.
- Evaluation of functional imaging, including octreotide scans and Gallium-68 somatostatin analog PET scans, for diagnosis and therapy guidance.
Main Results:
- Computed tomography (CT) scans and MRI are routinely used to evaluate tumor burden in neuroendocrine tumors (NETs).
- Functional imaging, such as octreotide scans and Gallium-68 somatostatin analog PET, is selectively employed for diagnosis confirmation and therapeutic guidance.
- Familiarity with the indications and interpretation of these imaging modalities is essential for healthcare professionals.
Conclusions:
- Imaging is indispensable for the comprehensive management of neuroendocrine tumors (NETs).
- A combination of anatomical and functional imaging provides critical information for diagnosis, prognosis, and treatment selection.
- Future advancements in functional imaging promise enhanced detection, personalized therapy, and novel treatment strategies for NETs.
Related Concept Videos
01:25Imaging Studies II: Positron Emission Tomography and Scintigraphy
Fundamental Principles of PET
01:27Imaging Studies IV: Magnetic Resonance Imaging
01:14Imaging Studies I: CT and MRI
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...